Current Opinion in Allergy and Clinical Immunology was launched in 2001. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of allergy and clinical immunology are divided into 14 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
Dr Milgrom has been on the staff of National Jewish Health (formerly National Jewish Medical and Research Center) in Denver, USA for over 25 years. He holds the appointment of Professor of Pediatrics at the University of Colorado School of Medicine, USA.
Dr Milgrom believes that the greatest challenge for healthcare in the 21st century is to provide proficient and cost-effective health management, especially as it pertains to chronic illness. Today's medicine is reactive. We are practicing 19th century medicine in the 21st century. We treat the sick with drugs most often chosen on the basis of common use. In the case of asthma, we and the patients use medications imperfectly resulting in suboptimal outcomes with unnecessary morbidity and cost. Healthcare of the future will be predictive and personalized. Systems medicine will become a major paradigm in clinical research, much as systems biology has become in the natural sciences. It will allow us to target therapy on a personalized basis for those who need it, avoiding treatment for those who do not. The strategy will center on the modern personal health record that provides integrated and comprehensive information as to the health of an individual. New technologies and availability of large databases will profoundly alter the way that outcomes research is conducted and knowledge is conveyed. It appears ever more probable that such information will provide unmatched understanding of a patient's condition, including susceptibility to disease and its progression, as well as the response to treatment. The goal of the right drug for the right patient at the right time just might be attainable. With the capacity to inject this new intelligence into health delivery, our challenge will be to put the patient first and not to lose track of what it takes to be a good physician. In an increasingly technological age caring and compassion must remain the foundation of healthcare.
René Maximiliano Gómez
Dr René Maximiliano Gómez gained his medical degree in 1991 at the Catholic University of Córdoba, Argentina and he will present his PhD thesis there in May 2016. He is a board certified specialist in allergy and immunology at the National University of Córdoba, Argentina and a consultant in the Allergy and Asthma Unit at Hospital San Bernardo in Salta, Argentina. He has previously worked as an assistant professor in immunology; veterinary sciences at the Catholic University of Salta, Argentina and Medical Director at Alas Medical Institute, Salta, Argentina. Dr Gómez is President of the Ayre Foundation which conducts education and research on allergy and respiratory diseases in Salta, Argentina, and a committee member on allergy diagnosis and molecular allergology at the World Allergy Organization. He began serving as Scientific Secretary at the Latin American Society of Allergy, Asthma and Immunology (SLaai) in 2013 and will hold the post until 2017. Dr Gómez has authored or co-authored almost 30 publications with more than 200 citations and over 800 reads (60.66 impact points on ResearchGate). His research focuses on allergens and indoor pollution in asthma/allergic rhinitis, parasites and atopy, chronic urticaria, allergen immunotherapy and registries for allergic diseases.
Alessandro Fiocchi, MD is the Director of Allergy at the Pediatric Hospital Bambino Gesù (OPBG), Rome, Vatican City. Formerly Director of Pediatrics at the Melloni University Hospital in Milan, Italy. He is an expert in the field of food allergy. After postgraduate degrees and professional qualifications in pediatrics, allergy medicine, pulmonology, and neonatology, he dedicated his research and clinical work to the care of children with asthma and allergic disease. Currently, he leads a research group focusing on food allergy, asthma, and specific immunotherapy. This group is based in the OPBG, a health care and research institution specialized in pediatric and developing ages. As the largest Pediatric Hospital in Italy, OPBG guarantees total coverage for all health care needs, including allergy.
Since 2001, he has organized international meetings in Milan, Italy, and other countries. He founded and presides over the Italian Research Foundation for Allergy and Asthma in Childhood – Allegria ONLUS, a charity dedicated to clinical and research studies. As Chair of the Adverse Reactions to Foods Committee of the American College of Allergy, Asthma, and Immunology, he co-chaired with Sami Bahna and Amal Assa’ad several International Food Allergy Symposiums, the last in Anaheim, November 2012. As Chair of the Special Committee on Food Allergy of the World Allergy Organization (WAO), he co-chaired with Hugh Sampson both the WAO Food Allergy Symposium in Bangkok, 2007, and in Buenos Aires, 2009. Under his chairmanship, WAO published the Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guidelines in 2010 and the Clinical Use of Probiotics in Pediatric Allergy (CUPPA) position paper on the use of probiotics in pediatric allergy. Since January 2014, Dr Fiocchi has been Editor-in-chief of the World Allergy Organization Journal. His publications cover the fields of food allergy diagnosis, follow-up, epidemiology, specific immunotherapy and childhood asthma.
Julie Wang, MD is an Associate Professor of Pediatrics at the Icahn School of Medicine at Mount Sinai in New York, USA. She graduated from the Weill Cornell Medical College in New York City, USA. She completed pediatric residency training at the New York-Presbyterian/Weill Cornell Medical Center in New York, USA and an allergy and immunology fellowship program at the Mount Sinai School of Medicine in New York, USA.
Dr Wang is an expert in the field of food allergy. Her current research focus is on novel therapeutic approaches to food allergy. She has been awarded a 5 year National Institute of Health grant to support her work investigating the effects of Traditional Chinese Medicine on food allergy. Her publications cover the fields of food allergy diagnosis, epidemiology, and therapeutics as well as asthma and food allergy in urban children. Dr Wang is a member of the American Academy of Asthma, Allergy and Immunology, American Academy of Pediatrics, and Society for Pediatric Research.